These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27161955)

  • 1. Pronounced between-subject and circadian variability in thymidylate synthase and dihydropyrimidine dehydrogenase enzyme activity in human volunteers.
    Jacobs BA; Deenen MJ; Pluim D; van Hasselt JG; Krähenbühl MD; van Geel RM; de Vries N; Rosing H; Meulendijks D; Burylo AM; Cats A; Beijnen JH; Huitema AD; Schellens JH
    Br J Clin Pharmacol; 2016 Sep; 82(3):706-16. PubMed ID: 27161955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
    Kralovánszky J; Adleff V; Hitre E; Pap E; Réti A; Komlósi V; Budai B
    Magy Onkol; 2007; 51(2):113-25. PubMed ID: 17660867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an oral uracil loading test to identify DPD-deficient patients using a limited sampling strategy.
    van Staveren MC; van Kuilenburg AB; Guchelaar HJ; Meijer J; Punt CJ; de Jong RS; Gelderblom H; Maring JG
    Br J Clin Pharmacol; 2016 Mar; 81(3):553-61. PubMed ID: 26551538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity.
    Meulendijks D; Henricks LM; Jacobs BAW; Aliev A; Deenen MJ; de Vries N; Rosing H; van Werkhoven E; de Boer A; Beijnen JH; Mandigers CMPW; Soesan M; Cats A; Schellens JHM
    Br J Cancer; 2017 May; 116(11):1415-1424. PubMed ID: 28427087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma.
    Toriumi F; Kubota T; Saikawa Y; Yoshida M; Otani Y; Watanabe M; Kumai K; Kitajima M
    Anticancer Res; 2004; 24(4):2455-63. PubMed ID: 15330198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro sensitivity to platinum-derived drugs is associated with expression of thymidylate synthase and dihydropyrimidine dehydrogenase in human lung cancer.
    Takizawa M; Kawakami K; Obata T; Matsumoto I; Ohta Y; Oda M; Sasaki T; Watanabe G
    Oncol Rep; 2006 Jun; 15(6):1533-9. PubMed ID: 16685392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients.
    Amatori F; Di Paolo A; Del Tacca M; Fontanini G; Vannozzi F; Boldrini L; Bocci G; Lastella M; Danesi R
    Pharmacogenet Genomics; 2006 Nov; 16(11):809-16. PubMed ID: 17047489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer: relationship between mRNA expression and activity.
    Miyoshi T; Kondo K; Fujino H; Takahashi Y; Sawada N; Sakiyama S; Tsuyuguchi M; Kimura S; Sumitomo M; Monden Y
    Anticancer Res; 2005; 25(2A):923-30. PubMed ID: 15868929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I pharmacological study of continuous chronomodulated capecitabine treatment.
    Roosendaal J; Jacobs BAW; Pluim D; Rosing H; de Vries N; van Werkhoven E; Nuijen B; Beijnen JH; Huitema ADR; Schellens JHM; Marchetti S
    Pharm Res; 2020 May; 37(5):89. PubMed ID: 32382808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of uracil, dihydrouracil, thymine and dihydrothymine for reliable dihydropyrimidine dehydrogenase (DPD) phenotyping critically depend on blood and plasma storage conditions.
    van den Wildenberg SAH; Streng AS; van den Broek R; Broeren MAC; Deenen MJ; van Dongen JLJ; Hanrath MA; Lapré C; Brunsveld L; Scharnhorst V; van de Kerkhof D
    J Pharm Biomed Anal; 2022 Nov; 221():115027. PubMed ID: 36099723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of sensitivity to 5-FU on the basis of thymidylate synthase (TS)/dihydropyrimidine dehydrogenase (DPD) activity and chromosomal analysis in micro tissue specimens of breast cancer.
    Ota D; Kusama M; Kaise H; Nakayama S; Misaka T; Tsuchida A; Aoki T
    Breast Cancer; 2004; 11(4):356-66. PubMed ID: 15604991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher Tissue Levels of Thymidylate Synthase Determined by ELISA Are Associated with Poor Prognosis of Patients with Lung Cancer.
    Shiina T; Saito G; Sakaizawa T; Agatsuma H; Tominaga Y; Hyogotani A; Hamanaka K; Toishi M; Takasuna K; Kondo R; Yoshida K; Ito KI
    Tohoku J Exp Med; 2017 Aug; 242(4):303-316. PubMed ID: 28835573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancies between the gene expression, protein expression, and enzymatic activity of thymidylate synthase and dihydropyrimidine dehydrogenase in human gastrointestinal cancers and adjacent normal mucosa.
    Miyamoto S; Ochiai A; Boku N; Ohtsu A; Tahara M; Yoshida S; Okabe H; Takechi T; Fukushima M
    Int J Oncol; 2001 Apr; 18(4):705-13. PubMed ID: 11251164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of thymidylate synthase and dihydropyrimidine dehydrogenase in penile cancer].
    Zhao F; Tang J; Gou HF; Li LH; Dong H; Chen Y; Cheng K; Ding J; Chen X; Men HT; Liu JY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):756-9. PubMed ID: 24325106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
    Fukui Y; Oka T; Nagayama S; Danenberg PV; Danenberg KD; Fukushima M
    Int J Mol Med; 2008 Dec; 22(6):709-16. PubMed ID: 19020767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian variation in intestinal dihydropyrimidine dehydrogenase (DPD) expression: a potential mechanism for benefits of 5FU chrono-chemotherapy.
    Abolmaali K; Balakrishnan A; Stearns AT; Rounds J; Rhoads DB; Ashley SW; Tavakkolizadeh A
    Surgery; 2009 Aug; 146(2):269-73. PubMed ID: 19628084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian expression of dihydropyrimidine dehydrogenase, thymidylate synthase, c-myc and p53 mRNA in mouse liver tissue.
    Wu MW; Xian LJ; Li XM; Pasquale I; Francis L
    Ai Zheng; 2004 Mar; 23(3):235-42. PubMed ID: 15025949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of tailored chemotherapy for advanced colorectal cancer with either 5-fluouracil and leucovorin or oxaliplatin and irinotecan based on the expression of thymidylate synthase and dihydropyrimidine dehydrogenase.
    Smorenburg CH; Peters GJ; van Groeningen CJ; Noordhuis P; Smid K; van Riel AM; Dercksen W; Pinedo HM; Giaccone G
    Ann Oncol; 2006 Jan; 17(1):35-42. PubMed ID: 16251201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.
    Ichikawa W; Uetake H; Shirota Y; Yamada H; Nishi N; Nihei Z; Sugihara K; Hirayama R
    Clin Cancer Res; 2003 Feb; 9(2):786-91. PubMed ID: 12576451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.